Latest Cancer Research Stories
KIRKLAND, QC, April 19, 2015 /CNW Telbec/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new data from KEYNOTE-001, a Phase 1b study evaluating pembrolizumab,
PALO ALTO, Calif., April 17, 2015 /PRNewswire/ -- Centrillion Technologies, a genomic technologies company, has received a SBIR grant from the National Human Genome Research Institute, part
Ubiquitin system produces a protein that greatly restricts the development of cancerous tumors NEW YORK, April 17, 2015 /PRNewswire-USNewswire/ -- Dr.
The second Tuesday of the month rolls around and we always wake up excited. Why? Because we know after a long day of work (Well, maybe not for us; we get to publish science stories all day), we get to attend the Science Club Nashville, where we'll kick back with a pint of the finest local beer and listen to a lecture from a leading local expert.
SAN DIEGO, April 16, 2015 /PRNewswire/ -- Epic Sciences announced today that its no cell left behind(TM) technology has successfully integrated single cell isolation and downstream
Two innovative medical technology companies, InSilico Medicine, Inc.
After almost five months of chemotherapy and radiation, the news was not good for Ken Cooper.
Study in Science Translational Medicine Confirms that Many Genetic Alterations Identified by Tumor-Only Sequencing are 'False Positives' BALTIMORE, April 15, 2015 /PRNewswire/ --
MADRID, April 14, 2015 /PRNewswire/ -- - Combination of the anticancer drug PM1183 with PARP inhibitors and doxorubicin results in a synergistic
Topping the list of new sports involved with Play4TheCure in 2015 is the addition of a pilot program with U.S.
- An armed gangster.